Bioanalytical Methods to Optimize Drug Development: Hybrid LC-MS vs LBA

Published on: 

Sponsored Video

Drs Dawn Dufield and Dominic Warrino, KCAS Bioanalytical and Biomarker Services, share expertise on using Hybrid LC-MS versus LBA for bioanalytical analysis.

Selecting the right bioanalytical method to support qualitative and quantitative analysis requires flexibility and expertise from a CRO equipped to adapt to industry advancements.

Learn more:

  • Understand when to use LC-MS, LBA or both.
  • Learn why keeping LBA and Hybrid LC-MS in the forefront of your studies can result in big benefits.
  • Understand the best method to optimize your drug development outcomes.